On October 26-27, China Hospital Quality Conference 2017 was grandly held in Nanjing. On the theme of "Excellence through Precision and Innovation through Integration", the conference brought together more than 1,200 well-known experts and hospital managers at home and abroad to share the latest practice and proven experience in the field of hospital quality and safety management.
China Hospital Quality Conference 2017
China Hospital Quality Conference is a grand gathering of hospital quality management brands hosted by Chinese Hospital Association. It has played an important role in strengthening the internal building of hospitals, improving medical quality, ensuring patients safety and promoting the healthy development of hospitals, and has become an authoritative and influential event in the industry.
The sub-forum on "Innovative Mechanism to Improve Medical Quality" organized by Hansoh Pharma was held on the morning of 27th, at which managers and experts from medical institutions in Beijing, Shanghai, Nanjing, etc. made keynote presentations on the theme of innovation management and medical quality. The forum helped hospital managers and experts to innovate their thinking and practice through experience sharing and dialogue discussions, and built an important learning and exchange platform for the participants.
sub-forum on "Innovative Mechanism to Improve Medical Quality" organized by Hansoh Pharma
Ms. Fu Caiyun, Executive Vice President of Hansoh Pharma, addressed at the forum: medical quality and safety are the core lifeline of hospital management, and medication safety is a prerequisite for hospital quality; as a domestic leading innovative pharmaceutical enterprise, Hansoh Pharma always upholds the corporate mission of "create excellence in pharmaceuticals,create excellence in pharmaceuticals, enhance innovation in Chinaserving society and building health", and strives to solve the problem of medication accessibility for Chinese people by focusing on innovation on one hand and quality on the other, making positive contributions to the continuous improvement of human health.
In 2012, Hansoh Pharmaintroduced performance excellence management, with the corporate mission of "serving society and building healthcreate excellence in pharmaceuticals,create excellence in pharmaceuticals, enhance innovation in China", the corporate vision of "becoming a world-class innovative pharmaceutical company", and the values of "responsibility, integrity, hard work and innovation" deeply rooted in the hearts of employees.
Under the guidance of its unique corporate culture, Hansoh Pharma has been firmly ranked among the industry's top three for independent innovation capability, and has achieved remarkable results in system establishment and team building. The company has three R&D centers and a number of national and provincial research platforms, and has established strategic partnerships with a number of top research institutes and medical institutions at home and abroad; it now has nearly 20 innovative drugs at various clinical stages and 1 innovative drug under multi-center clinical trials worldwide, marking that Hansoh Pharma has officially entered a new stage of "scientific research worldwide" from "preparation products worldwide". Under the guidance of the people-oriented talent development concept, Hansoh Pharma has trained a number of experts who enjoy special allowances from the State Council and are included in talent programs such as "Jiangsu Innovation and Startup Program" and "Jiangsu 333 Talent Program", and has established a number of R&D teams with them as the core.
At the same time, under the guidance of the quality policy of "all staff, whole process and continuous improvement", Hansoh Pharma has established a production quality management system for the whole life cycle and introduced world-class production equipment to provide Chinese patients with high-quality drugs that meet EU and US FDA quality standards. In the future, Hansoh Pharma will go hand in hand with its global counterparts to innovate and develop, and devote itself to the improvement of China's medical and health level and the development of human health.
